KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Vir Biotechnology (VIR) Cost of Revenue (2021 - 2025)

Vir Biotechnology's Cost of Revenue history spans 5 years, with the latest figure at $11000.0 for Q2 2025.

  • On a quarterly basis, Cost of Revenue fell 78.85% to $11000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $745000.0, a 21.33% decrease, with the full-year FY2025 number at $26000.0, down 96.92% from a year prior.
  • Cost of Revenue hit $11000.0 in Q2 2025 for Vir Biotechnology, down from $684000.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for VIR hit a ceiling of $90.1 million in Q1 2022 and a floor of $11000.0 in Q2 2025.
  • Historically, Cost of Revenue has averaged $13.5 million across 5 years, with a median of $971000.0 in 2021.
  • Biggest five-year swings in Cost of Revenue: surged 2340.65% in 2022 and later plummeted 99.92% in 2023.
  • Tracing VIR's Cost of Revenue over 5 years: stood at $56.9 million in 2021, then crashed by 89.46% to $6.0 million in 2022, then plummeted by 86.69% to $798000.0 in 2023, then dropped by 14.29% to $684000.0 in 2024, then tumbled by 98.39% to $11000.0 in 2025.
  • Business Quant data shows Cost of Revenue for VIR at $11000.0 in Q2 2025, $684000.0 in Q4 2024, and $50000.0 in Q3 2024.